Herpesvirus latency

J Clin Invest. 2020 Jul 1;130(7):3361-3369. doi: 10.1172/JCI136225.

Abstract

Herpesviruses infect virtually all humans and establish lifelong latency and reactivate to infect other humans. Latency requires multiple functions: maintaining the herpesvirus genome in the nuclei of cells; partitioning the viral genome to daughter cells in dividing cells; avoiding recognition by the immune system by limiting protein expression; producing noncoding viral RNAs (including microRNAs) to suppress lytic gene expression or regulate cellular protein expression that could otherwise eliminate virus-infected cells; modulating the epigenetic state of the viral genome to regulate viral gene expression; and reactivating to infect other hosts. Licensed antivirals inhibit virus replication, but do not affect latency. Understanding of the mechanisms of latency is leading to novel approaches to destroy latently infected cells or inhibit reactivation from latency.

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Animals
  • Antiviral Agents / therapeutic use
  • Gene Expression Regulation, Viral / physiology*
  • Herpesviridae / physiology*
  • Herpesviridae Infections / drug therapy
  • Herpesviridae Infections / genetics
  • Herpesviridae Infections / metabolism*
  • Humans
  • Virus Activation / drug effects
  • Virus Activation / physiology*
  • Virus Latency / drug effects
  • Virus Latency / physiology*

Substances

  • Antiviral Agents